ANNABEL E. BARBER, M.D., F.A.C.S.

Department of Surgery
University of Nevada School of Medicine

Schedule an Appointment

CURRICULUM VITAE

Education

Medical M.D., 1985 - University of Texas Medical School at Houston Undergraduate B.A., Biology and Chemistry, 1981 - Mary Baldwin College, Staunton, Virginia

Professional Experience
Internship General Surgery
New York Hospital-Cornell University Medical College
1985-1986

Residency General Surgery
New York Hospital-Cornell University Medical College
1986-1988

Research Fellow Surgical Nutrition and Metabolism
New York Hospital-Cornell University Medical College
1988-1990

Residency General Surgery
New York Hospital-Cornell Uiversity Medical College
1990-1992

Assistant Professor Department of Surgery
Texas Tech Health Sciences Center Lubbock, Texas
July 1992 - July 1997

Department of Surgery
Clerkship Director Third Year Medical Students
3/95 to 7/97

Department of Surgery Representative
Risk Management Committee

Trauma Services Committee Member
University Medical Center

Chief Cancer Liaison Physician of the Commission on Cancer, Southwest Cancer Center at University Medical Center Lubbock, Texas


Assistant Teaching University Medical Center Physician Lubbock, Texas
1992 - 1997

Associate Professor University of Nevada School of Medicine
Las Vegas, Nevada
8/97 – Present

Tenured University of Nevada School of Medicine
Las Vegas, Nevada
7/03

Chief, General Surgery Mountainview Hospital
Las Vegas, NV
1/02 – 1/05

Chief, General Surgery Clinics University Medical Center
Las Vegas, NV
6/03 - Present

Professional Societies

Fellow, American College of Surgeons
Society of University Surgeons
Society of Critical Care Medicine
American Society of Parenteral and Enteral Nutrition
Surgical Infection Society
The Society for Surgery of the Alimentary Tract
Societe Internationale De Chirugie
Nevada Oncology Society
American Society of Breast Surgeons
The Society of Laparoendoscopic Surgeons

Honors and Awards

Phi Beta Kappa
Omicron Delta Kappa
Beta Beta Beta (Biology)
Iota Sigma Pi (Chemistry)
Upjohn Award for Excellence UT Medical School
Harry M Vars Award (Nutrition research)
New York Academy of Medicine Resident Research
Swarthmore’s Who’s Who-2000
2002 Top Doctors List
2002-2003 America’s Registry of Outstanding Professionals
2003 Best Doctors Database
2003-2004 Best Doctors in America
2006 Swarthmore’s Who’s Who; Professional of the year Education/Surgery
2006 Edition Great Women of the 21st Century

Award

American Cancer Society, Clinical Fellowship in Oncology

Certification

Basic Life Support

Advanced Cardiac Life Support

Advanced Trauma Life Support

American Board of Surgery

February 9, 1993, Certificate No. 37968

Research

Synthesis of chelating agents, Mary Baldwin College, 1980

Immunosuppression with Lead-212 labeled liposomes, Argonne National Laboratory, 1980

Cyclosporine and skin homografting University of Texas Medical School at Houston, 1985

Gut barrier failure and metabolic response to injury, Cornell University Medical College, 1988-1990

Co-investigator, Evaluations of saline solutions in therapy of shock. Grant #5R376M23000-20. Texas Tech University School of Medicine 1992-1997

Principal Investigator, IL-1ra vs. placebo in a double blinded multicenter clinical trial in septic patients, Synergen, Inc. 7/93 to 7/94

Principal Investigator, rhIGF in Acute Renal Failure trial, Chiron Corporation 5/95 to 5/96

Principal Investigator, Prospective double blind, placebo controlled, randomized, multicenter North American Study of safety and efficacy of murine monoclonal antibody to tumor necrosis factor (TNF Mab) for the treatment of patients with septic shock, Bayer Corporation, 4/95 to 3/97

Principal Investigator, A randomized, open-label, dose-finding parallel group study of intrapleural Batimastat (BB-94) in patients with malignant pleural effusion, British Biotech, Inc., 8/95 to 9/96

Principal Investigator, A double-blind, randomized, placebo-controlled, multi-center trial to evaluate the efficacy and safety of two doses of Lexipafant for the treatment of acute pancreatitis, British Biotech, Inc., 8/95 to 4/99

Event Classification Committee, a double-blind, randomized, placebo controlled, multi-center trial to evaluate the efficacy and safety of two doses of Lexipafant for the treatment of acute pancreatitis, British Biotech, Inc., 8/95 to 4/99

Co-Investigator, National Surgical Adjuvant Breast and Bowel Project (NSABP) Protocol No. R-03, B-21, B-23, B-27, B-28, 10/96 to 8/98

Principal Investigator, A Phase II Study of Antithrombin III in Patients with Non-shock sepsis, Bayer Corporation 3/97 to 10/98

Principal Investigator, A Phase II Multi-Center, Randomized, Placebo Controlled, Two-Step Dose Escalation Safety Tolerability and Hypothesis Generating Trial of Recombinant Tissue Factor Pathway Inhibitor (rTFPI, SC 59735) in Sepsis Patients (CS-TF004), Chiron Corporation, 3/97 to 12/98

A Phase III, Double-Blind, Randomized, Placebo-Controlled, Multi-Center Trial to Assess the Effect of Lexipafant on the Incidence of Acute Pancreatitis in Patients Undergoing an Endoscopic Retrograde Cholangiopancreatography, British Biotech, 11/98 to 4/99

A Phase II Study to Evaluate the Safety and Efficacy of Recombinant Platelet Activating Factor Acetylhydrolase (rPAF-AH) for the Prevention of Acute Respiratory Distress Syndrome in Patients with Severe Sepsis or Severe Traumatic Injuries, ICOS Corporation, 9/98 to 9/99.

A Randomized, Dose Comparative Phase II/III Study of Ziracin in the Treatment of Serious Infections Due to Vancomycin-Resistant Enterococci, Schering-Plough Corporation, 1998 to 9/99.

A Multi-Center, single-Blind, Placebo-Controlled, Randomized, Dose Escalation Study of Recombinant Tissue Factor Pathway Inhibitor (r TFPI/SC-59735) in Severe Sepsis, Chiron Corporation, 1998 to 1999.

A Randomized Double-Blind, Phase III Study of Ziracin in the Treatment of Moderate to Severe Acute Bacterial Pneumonia due to S. pneumoniae, Schering-Plough, 1998 to 1999.

A Randomized, Double-Blind, Comparative Phase II Study of the Safety and Efficacy of Ziracin vs. Vancomycin in the Treatment of Serious Gram-positive Infections, Schering-Plough, 1998 to 2000.

A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Phase III Study of Intravenous Betafectin PGG-Glucan for the Prevention of Serious Infections in Patients Undergoing Upper Gastrointestinal Surgery Who Are AT Risk for Infection, Alpha Beta Technology Corporation, 1998.

Study of Cytokine Manipulation In Septic and Hemorrhagic Shock, 1992 to present.

Reversal of Cancer Cachexia with HMB Supplementation, 1998 to present.

A Phase II Study to Evaluate the Safety and Efficacy of Recombinant Platelet Activation factor Acetylhydrolase (rPAF-AH) for the Treatment of Patients with Severe Acute Pancreatitis, 1999 to 2000.

A Multi-Center, Single-Blind, Placebo-Controlled, Randomized Study of Recombinant Tissue Factor Pathway Inhibitor (r TFPI/SC-59735) in Severe Sepsis, Chiron Corporation, 2000 to 2001.

A Phase 3 Study to Demonstrate the Safety and Efficacy of Recombinant Platelet Activating Factor Acetylhydrolase (rPAF-AH) For Reducing 28 Day All Cause Mortality in Patients with Severe Sepsis, 2001- 2002

A Phase II, Mulitcrenter, Randomized,Double-Blind, Placebo-Controlled, Parallel-group, Dose-ranging Evaluation of the Safety and Efficacy of 2lpha-hANP Infusion (Carpeitide for Injection: (SUN 4936) in Patients with Acute Respiratory Distress Syndrome (ARDS), 2001- 2002

A randomized, prospective trial studying the anticatabolic effects of ß-hydroxy–ß-methylbutryate (HMB) on patients with cancer and the correlation of cancer staging to resting energy expenditure (REE) and cytokine profile, 2002 - 2005

ß-hydroxy–ß-methylbutryate Supplementation in Critically Ill Patients. 2004 – Present

Treatment of Gastroparesis with Gastric Electrical Stimulation. 2005 – Present

Committees

Multidisciplinary Breast Conference
Sunrise Hospital
Las Vegas, NV
2004 – Present

Credentials Committee Chairperson
Mountainview Hospital
Las Vegas, NV
2005 - Present

Medical Executive Committee
Las Vegas Surgery Center
Las Vegas, NV
2001 – Present

Quality Council Committee
Mountainview Hospital
Las Vegas, NV
2003 – 2005

Surgery Committee
Mountainview Hospital
Las Vegas, NV
2001 – 2005

Cancer Committee
Summerlin Hospital
Las Vegas, NV
2000 – Present

American College of Surgeons
Nevada Chapter Council
Las Vegas, NV
2000 – Present

American College of Surgeons
Secretary/Treasurer of the Nevada Chapter
Las Vegas, NV
May 2006 – Present

MountainView Hospital
Board of Trustees
January 2007 – Present

Publications

1. Moldawer LL, Bushman ED, Barber AE, Marano MA, Keogh CV, Fong Y, Helfgott DC, May LT, Sehgal P, Lowry SF, Interleukin -1 and Interleukin -6 synergize to increase plasma amyloid P and C3 concentrations in the mouse. Ann NY Acad Sci 557:528-531, 1989.
2. Fong Y, Moldawer LL, Marano MA, Wet H, Barber AE, Fischman DA, Lowry SF. Starvation leads to decreased levels of mRNA for myofibrillar proteins. J Surg Res 46:457-461, 1989.
3. Fong Y, Marano MA, Barber AE, Wei H, Moldawer LL, Bushman ED, Coyle SM, Shires GT, Lowry SF. Total parenteral nutrition and bowel rest modify the metabolic response to endotoxin in humans. Ann Surg 210:449-457, 1989.
4. Fong Y, Moldawer LL, Marano M, Wei H, Barber AE, Mangogue K, Tracey KJ, Kuo G, Fischman DA, Cerami A, et al. Cachectin/TNF or IL-lalpha induces cachexia with redistribution of body proteins. Am J Physiol 256:659-665, 1989.
5. Barber AE, Jones WG, Minei JP, Moldawer LL, Fahey TJ, Lowry SF, Shires GT: Composition and functional consequences of fiber and glutamine supplementation of elemental diets. Surg Forum 40:15-17, 1989.
6. Jones WG, Minei JP, Barber AE, Moldawer LL, Fahey TJ, Shires III GT, Lowry SF, Shires GT. Elemental diet promotes spontaneous bacterial translocation and alters mortality after endotoxin challenge. Surg Forum 40:20-22, 1989.
7. Marano MA, Fong Y, Moldawer LL, Wei H, Barber AE, Gershenwald JE, Fischman DA, Lowry SF. Differential metabolic response of myocardial versus skeletal muscle during catabolic post-burn infection. Surg Forum 40:20-22, 1989.
8. Jones, WG II, Barber AE, Fahey TJ, Shires GT III, Shires GT. Angiotensin converting enzyme inhibition (ACEI) decreases bacterial translocation after burn injury. FASEB J. 1990 Feb. 28; 4(4): A953.
9. Jones, WG II, Barber AE, Fahey TJ, Shires GT III, Shires GT. Angiotensin converting enzyme inhibition (ACEI) decreases bacterial translocation after burn injury (abs.). FASEB J. 4(4): 3988, 1990.
10. Jones WG, Minei JP, Barber AE, Rayburn JL, Rahey TJ, Shires III GT, Shires GT. Bacterial translocation and intestinal atrophy following thermal injury and burn wound sepsis. Ann Surg 211:399-405, 1990.
11. Keogh C, Fond Y, Marano MA, Wei W, Barber AE, Minei JP, Lowry SF, Moldawer LL. Identification of a novel tumor necrosis factor/cachectin from the livers of burned and infected rats. Arch Surg 125:89-85, 1990.
12. Barber, AE, Jones WG, Minei JP, Fahey TJ, Moldawer LL, Rayburn JL, Fischer E, Shires GT, Lowry SF. Glutamine or fiber supplementation of a defined formula diet: impact on bacterial translocation, tissue composition, and response to endotoxin. JPEN 14:335-242, 1990.
13. Jones WG, Barber AE, Minei JP, Fahey TJ, Shires GT III, Shires GT. Antibiotic prophylaxis diminishes bacterial translocation but not mortality in experimental burn would sepsis. J Trauma 30:737-740, 1990.
14. Barber AE, Coyle SM, Fong Y, Fischer E, Marano MA, Calvano SE, Moldawer LL, Shires GT, Lowry SF. Impact of hypercortisolemia on the metabolic and hormonal responses to endotoxin in man. Surg Forum 41:74-77, 1990.
15. Jones WG, Minei JP, Barber AE, Fahey TJ, Shires III GT, Shires GT. Additive effects of thermal injury and infection on the small bowel. Surgery108:63-70, 1990.
16. Jones WG, Barber AE, Leconte YP, Fahey TJ, Koplin B, Cerami A, Tracey KJ, Shires GT. Tumor necrosis factor (TNF) promotes bacterial translocation in tumor-bearing mice. Surg Forum 41: 94-96, 1990.
17. Rock CS, Barber AE, Eng-Hen N, Jones WG, Roth MS, Moldawer LL, Lowry SF. TPN vs. Oral feeding: bacterial translocation, cytokine response and mortality following E. coli LPS administration. Surg Forum 41: 14-16, 1990.
18. Coyle SM, Barber AE, Fond Y, et al: Hormone-cytokine responses to total parenteral nutrition to humans. Abstr. Clin Nutr 1990: 9:20.
19. Jones WG, Minei JP, Richardson RP, Fahey TJ, Antonacci AC, Shires III GT, Shires GT. Pathophysiologic glucocorticoid elevations promote bacterial translocation after thermal injury. Infect Immun 58: 3257-3261, 1990.
20. Wang, RC, Goepfert H, Barber AE, Wolf P. Unknown primary squamous cell carcinoma metastatic to the neck. Arch Otolaryngol Head Neck Surg 116: 1388-1393, 1990.
21. Jones WG, Barber AE, Kapur S, Hawes AJ, Fahey TJ, Minei JP, Calvano SE, Shires GT III, Shires GT. Pathophysiologic glucocorticoid levels and survival of translocating bacteria. Arch Surg 126:50-55, 1991.
22. Barber AE, Jones WG, Minei JP, Fahey TJ, Lowry SF, Shires GT. Bacterial overgrowth and intestinal atrophy in the etiology of gut barrier failure in the rat. Am J Surg 161: 300-304, 1991.
23. Jones WG, Minei JP, Barber AE, Fahey TJ, Shires III GT, Shires GT. Splanchnic vasoconstriction and bacterial translocation after thermal injury. Am J Physiol 30(4): H1190-H1196, 1991.
24. Jones WG, Barber AE, Minei JP, Fahey TJ, Shires III GT, Shires GT. Differential pathophysiology of bacterial translocation after thermal injury and sepsis. Ann Surg 214: 24-30, 1991.
25. Fahey TJ, Sadaty A, Jones WG, Barber AE, Smoller B, Shires GT. Diabetes impairs the late inflammatory response to would healing. J Sur Res 50: 308-313, 1991.
26. Fischer E, Marano MA, Barber AE, Hudson A, Lee K, Rock CS, Hawes AS, Thompson RC, Hayes TJ, Anderson TD, Benjamin WR, Lowry SR, Moldawer LL. Comparison between effects of Interleukin - la administration and sublethal endotoxemia in primates. Am J Physiol 261: R442-R452, 1991.
27. Jones WG, Barber AE, Fahey TJ, Krieger KH, Shires GT, Isom OW. Cardiopulmonary bypass is associated with early gut barrier dysfunction. Surg Forum 42:282-284, 1991.
28. Chiao JJC, Jones II WG, Shires III GT, Barber AE, Shires GT. Effect of sepsis on intracellular sodium activity, sodium concentration, and water content in thermal injury rat. Circ Shock 38:42-49, 1992.
29. Kapur S. Jones WG, Barber AE, Minei JP, Fahey TJ, Shires GT. Effects of cyclosporine treatment on the adrenocortical response to injury and infection in rats. Jour Sur Res 53:357-361, 1992.
30. Calvano SE, Barber AE, Hawes AS, DeRiesthal HF, Coyle SM, Lowry SE. Effect of combined cortisol-endotoxin administration of peripheral blood leukocyte numbers and phenotype in normal humans. Arch Surg 127:181-186, 1992.
31. Barber AE, Illner H, Shires GT. Bacterial Translocation in Burn Injury. Seminars in Nephrology. 1993 13(4): 416-419.
32. Barber AE, Coyle SM, Marano MA, Fisher E, Calvano SE, Fond Y, Moldawer LL, Lowry SF. Glucocorticoid therapy alters hormonal and cytokine responses to endotoxin in man. J Immunol 150:1999-2006, March 1993.
33. Sindlinger JF, Soucy DM, Green SP, Barber AE, Illner H, Shires GT. The effects of isotonic saline volume resuscitation in uncontrolled hemorrhage. Surg Gyn & Obst, 177(6):545-550, December 1993.
34. Barber AE, Millikan WJ, Illner H, Shires GT: Hemorrhagic shock severely impairs liver function. 3rd International Congress on the Immune Consequences of Trauma, Shock and Sepsis Mechanisms and Therapeutic Approaches, March 2-5, 1994, Munich, Germany.
35. Shires GT, Barber AE, Illner HP. Current status of resuscitation: Solutions including hypertonic saline. Adv Surg, Vol. 28; 133-170, 1995.
36. Soucy DM, Sindlinger JF, Greene SP, Barber AE, Illner HP, Shires GT. Isotonic saline resuscitation in uncontrolled hemorrhage under various anesthetic conditions. Ann Surg, 222:87-93, July 1995.
37. Barber AE, Coyle SM, Fischer E, Smityh C, van de Poll T, Shires GT, Lowry SF. Influence of hypercortisolemia upon levels of soluble TNF receptor and Interluekin-1 receptor antagonist responses to endotoxin in man. Surgery 118: 406-411, August 1995.
38. Soucy DM, Sindlinger JF, Greene SP, Barber AE, Illner H, Shires GT. Effects of anesthesia on a model of uncontrolled hemorrhage in rats. Critical Care Med, Vol. 23:9, 1528-1532, September 1995.
39. Keung YK, Gendreau J, Barber AE, Cobos E. Acute mediastinitis secondary to leakage of parenteral nutrition from a migrated central venous catheter in a patient undergoing autologous bone marrow transplant. Bone Marrow Transplantation (1996) 17, 871-872.
40. Barber AE, Shires GT. Cell damage after shock. New Horizons, Vol. 4:2, 161-167, May 1996.
41. Dilworth D., Barber AE, Illner H, Shires GT. Effectiveness of topical cerium nitrate in reducing hepatic cytokine production in the burned rat Crit Care Med, 1997, 25(1): A137.
42. Vander Poll T, Barber AE, Coyle SM, Lowry SF. Interleukin-10. J. Clin Endocrinol Metab. 1996 Oct.; 81:3604-6.
43. Keung YK, Cobos E, Barber AE, Ronaghan CA, Whitehed R, Station M, Gilbert M, Morgan D. Relationship between activated protein C resistance and central venous device-related complications. Clin Appl Thrombosis/Hemostasis, 3(2): 133-136, 1997.
44. Dilworth D, Barber AE, Illner H, Millikan WJ, Shires GT. Hepatic expression of various cytokines in the cirrhotic rat during hemorrhage shock. 4th International Congress on the Immune Consequences of Trauma, Shock and Sepsis - Mechanisms and Therapeutic Approaches, March 1997, 545-548.
45. Opal S, Fisher C, Jr., Dhainaut J, Barber AE, et. al. Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: A phase III, randomized, double-blind, placebo-controlled, multicenter trial. Critical Care Medicine 1997 Jul:25(7) 1115-24.
46. Greene, SP, Soucy, DM, Song, WC, Barber AE, Hagedorn FN, Illner HP, Shires GT. Early Isotonic Saline Resuscitation from uncontrolled hemorrhage in rats. Surgery 1998 Sep; 124 (3): 568-74.
47. Barber AE, Effects of Hypercortisolemia on Markers and Patterns of the Immune Response. Journal for Anesthesia and Intensive Care. 1999 Jan.; 195-97.
48. Mazolewski R, Barber AE, Williams S, M.S., Simoni J, PhD., Davis S, Shires, GT. Attenuating Tumor Necrosis Factor A Does Not Ameliorate Other Cytokine and Peroxidase Products during Sepsis. American Journal of Surgery, 1999, 178: 556-559.
49. Fisher B, Barber AE, Gastric bypass procedures. European Journal of Gastroenterology & Hepatology 1999,11: 93-99.
50. Illner H.,Barber AE, MD, Dilworth D, Griswold J., Noll R., Clinical Trials of New anti-Microbial and Anti-Fungal Treatment for Central Venous Catheters. Journal of Burn Care & Rehabilitation; in press.
51. Santibanez-Gallerani AS, Barber AE, Williams SL, Zhaoy Y, Shires GT. Hepatic integrity dependent on matrix metalloproteinase inhibition, not tumor necrosis factor alpha or different bleeding rates. J Surg Res. 2000 May 15;90 (2) 156-60.
52. Shires GT, Santibanez-Gallerani AS, Barber AE, Williams SJ, Davis D, Zhao Y. Matrix metalloproteinase inhibition protects hepatic integrity in hemorrhagic shock. Gastroenterology, April 1999, 116(4): 1354.
53. Shires GT, Santibanez-Gallerani AS, Barber AE, Williams SJ, Davis D, Zhao Y. Matrix metalloproteinase inhibition protects hepatic integrity in hemorrhagic and septic shock. J Gastrointestinal Surg, September 2000, 4(5): 536-541.
54. Santibanez-Gallerani AS, Barber A, Williams SJ, Mazolewski P, Avansino J, Murray B, Davis S, Zhao Y, Shires GT: Hepatic protection in E. Coli septic shock as well as hemorrhagic shock by MMPI inhibition. Gastroenterology Suppl 2 Part 1 SSAT 2267 April 2000, 118(4).
55. Sabbath A, Barber AE, Williams SJ, Zhao Y, Shires GT: Post-thermal injury serum levels of interleukin-6 and tumor necrosis factor in male Sprague Dawley rats. J Investigatieve Med 2000 48(1); 34a.
56. Santibanez-Gallerani, AS, Barber A, Williams SJ, Zhao Y, Shires GT: Improved Survival with Early Fluid Resuscitation Following Hemorrhagic Shock. World J. Surg. 25, 592-597, 2001.
57. Santibanez-Gallerani AS, Barber A, Williams SJ, Zhao Y, Shires GT: Hepatic integrity dependento on matrix metalloproteinase inhibition- not TNF-a or different bleeding rates. J Surg Res, May 2000.
58. May PE, Barber A, D’Olimpio JT, Hourihane A, Abumrad NN; Reversal of cancer-related wasting using oral supplementation with a combination of B-hydroxy-B-methylbutyrate, arginine and glutamine. Amer J Surg 183, 4, 471-479, 2002.
59. Browder T, Layson J, Williams SJ, Zhao Y, Barber AE, Shires GT: The third space defined in traumatic injury. Submitted. Archives of Surgery 2002
60. Browder T, Layson J, Barnes R, Sabbath A, Murray B, Williams SJ, Zhao Y, Barber AE, Shires GR: Cytokine responses to burn injury submitted J Burn Care, 2002
61. Browder T, Layson J Williams SJ, Zhao Y, Barber AE, Shires GT: Burn injury cytokine response to local cerium nitrate. Submitted Archives of Surgery.
62. Shires GT, Browder LK, Steljes TP, Williams SJ, Browder TD, Barber AE. The effect of shock resuscitation fluids on apoptosis. Am J Surg. 2005 Jan;189(1):85-91.
63. Browder L, Williams SJ, Zhao, Y, Barber AE, Shires GT: Detection of Apoptosis in burn injury. In preparation. 2002.
64. Kuhls DA, Rathmacher JA, Musngi MD, Frisch DA, Nielson J, Barber AE, MacIntyre AD, Coates JE, Fildes JJ. ß-hydroxy–ß-methylbutryate Supplementation in Critically Ill Patients. Submitted to Journal of Trauma 2005
65. Rathmacher JA, Nissen S, Panton L, Clark RH, Eubanks May P, Barber AE, D'Olimpio J, Abumrad NN. Supplementation with a combination of beta-hydroxy-beta-methylbutyrate (HMB), arginine, and glutamine is safe and could improve hematological parameters. JPEN J Parenter Enteral Nutr. 2004 Mar-Apr;28(2):65-75.
66. Spitzer AL, Barcia AM, Schell MT, Barber A, Norman J, Grendell J, Harris HW. Applying Ockham's Razor to Pancreatitis Prognostication: A Four-Variable Predictive Model. Ann Surg. 2006 Mar;243(3):380-388.

Published Abstracts

Barber AE, Merrell R. The effects of cyclosporine on skin autografts and skin allografts in rats - a histologic study. Clinical Research, 33:926 a, 1985.

Helfgott DC, Fong Y, Moldawer LL, Marano MA, Barber A, Wei H, May LT, Lowry SF, Sehgal PB. Human interleukin-6 is an endogenous pyrogen. Clinical Research 37(2):564A, 1989.

Barber AE, Marano MA, Fong Y, Coyle SM, Bushman ED, Gershenwald JE, Rosenbaum M, Lemack G, Gertner JM, Lowry SF. Circadian rhythms of growth hormone and cortisol in parenterally fed man. Clin Nut. (Special supplement) 8:50, 1989. (presented at the 11th Congress of the European Society of Parenteral and Enteral Nutrition, Helsinki, Finland, September 10-13, 1989).

Marano MA, Fong Y, Barber, A, Wei H, Moldawer LL, Calvano SE, Hesse D, Albert JD, Legaspi A, Lowry SF. Energy expenditure response to thermal injury hormone background, and endotoxin in man. Proceedings of the 21st Annual Meeting of the American Burn Association, New Orleans, LA, March 29-April 1, 1989.

Jones, WG, Barber AE, Minei JP, et al. Impact of fluid resuscitation and xanthine oxidase inhibition on gut barrier failure associated with burn wound sepsis. Proc Am Burn Assoc 1990; 22:55.

Soucy D, Sindlinger J, Green S, Barber AE, Illner H, Shires GT. The effects of anesthesia on uncontrolled hemorrhage in rats. Critical Care Medicine, 1/94, p.A218 (presented at the 23rd Educational and Scientific Symposium, Orlando, Florida, January 31-February 3, 1994.

Barber AE, Hsia WC, Illner H, Shires GT. Cyclosporine enhances endotoxin clearance in burn would sepsis. 9th Congress of the International Society for Burn Injuries. June 27-July 1, 1994. Paris, France.

Barber AE. Clinical Trials of New Anti-Microbial and Anti-Fungal treatment for Long Term Catheters. Submitted to the American Burn Association.

Barber AE, Metzler M, Schuster D. Recombinant Platelet-Activating Factor Acetylhydrolase (Pafase®) Improves Organ Dysfunction and Survival in Patients With Severe Sepsis. SCCM Critical Care Congress, January 26-30, 2002, San Diego, CA.

Barber AE, Browder T, Layson J, Barnes R, Sabbath A, Murray B, Williams SJ, Zhao Y, Shires GT. Thermal Injury to Skin Does Not Induce TNF and IL-6 Expression. University of Nevada School of Medicine, Department of Surgery. Las Vegas, NV. Presented at Western Surgical July 2002.

Kuhls DA, Rathmacher JA, Musngi MD, Frisch DA, Nielson J, Barber AE, MacIntyre AD, Coates JE, Fildes JJ. ß-hydroxy–ß-methylbutryate Supplementation in Critically Ill Patients. Presented at the 64th Annual Meeting of the American Association for the Surgery of Trauma. September 22-24, 2005, Atlanta, Georgia

Invited Lectures

"The Glutamine Controversy" presented to the Sylvia Griffith Society for Parenteral and Enteral Nutrition, May 5, 1994.

"Surgical Options in Colorectal Cancer" presented to the Forum on Colorectal Cancer: Detection-Prevention-Treatment, June, 1994.

“Effects of Hypercortisolemia on Markers and Patterns of the Immune Response ” presented to the 9th International Symposium for Intensive Medicine and Intensive Care, February, 1999.

Update Your Medicine, “Current Treatment of Breast Cancer”, 1998.

“Breast Cancer -For The Lay Audience”, Horizon of Hope-Longenberger Group, 1999.

“What’s new in breast cancer treatment” 1st Ladies conference on Women’s Health Care Issues, November, 2001

“New Surgical Techniques in Breast Surgery” Association of Technologies, 37th Annual National Conference, May, 2006

Chapters

1. Wang, RC, Goepfert H, Barber AE, Wolf PF. Squamous cell carcinoma metastatic to the neck from an unknown primary site. In Larson, D., Cancer in the Neck: Evaluation and Treatment. Macmillan, New York, 1987.
2. Shires GT, Barber AE, Illner HP: Current Status of Resusciation: Solutions Including Hypertonic Saline. In Shires GT, ed: Advances in Surgery, 28: 133-17-. Mosby, Chicago, Year Book, 1995.
3. Shires III GT, Barber AE, Shires GT. Fluid and electrolyte management of the surgical patient in Principles of Surgery. Seventh Edition. McGraw-Hill, Inc., New York, 1998, p. 53-76.
4. Barber AE, Shires III GT and Shires GT. Shock, in Principles of Surgery, Seventh Edition. McGraw-Hill, Inc. New York, 1998, p. 101-122.